DOI: 10.12890/2025_005419
VEXAS syndrome in a Moroccan patient: the story of a two-year diagnostic lag
Authors
lilia-zizi@hotmail.fr
Keywords
VEXAS syndrome, myelodysplastic syndrome, autoinflammation, immune dysregulation, geneticsAbstract
Background: VEXAS syndrome, also known as vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome, is a newly identified genetic condition characterised by a combination of autoinflammatory symptoms and myeloid dysplasia. The initial description was documented in 2020 and since then, there has been an increasing number of cases and series reported globally.
Case description: We present a case of VEXAS syndrome in an 88-year-old male patient. The patient has a p.Met41Val mutation in the UBA1 gene with notable skin, joint and lung involvement. As far as we know, this is the first documentation of VEXAS syndrome in Morocco and Africa. This condition may exhibit characteristics of recurrent fever, neutrophilic dermatitis, arthritis and chondritis, along with cytopaenias and myelodysplastic syndrome. The p.Met41Val mutation is known to be associated with severe clinical presentation and poor prognosis, with less chondritis involvement and more undifferentiated inflammatory syndrome, as seen in the described case.
Conclusions: VEXAS syndrome represents a prototype for a new classification of diseases, although it is still insufficiently identified in many underdeveloped countries, especially in Africa. It should be considered in elderly males with unexplained fever associated with systemic manifestations and worsening haematologic abnormalities.
References
- Hochman MJ, DeZern AE. Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin? Lancet Haematol 2022;9:e523–e534. doi: 10.1016/S2352-3026(22)00138-7
- Lynch OF, Calvi LM. Immune dysfunction, cytokine disruption, and stromal changes in myelodysplastic syndrome: a review. Cells 2022;11:580. doi: 10.3390/cells11030580
- Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med 2020;383:2628–2638. doi: 10.1056/NEJMoa2026834
- Georgin-Lavialle S, Terrier B, Guedon A, Estibaliz L, Heiblig M, Comont T, et al. Observatoire français de 116 patients avec un syndrome VEXAS: corrélation phénotype–génotype et prise en charge. Rev Médecine Interne 2021;42:A297–A298. doi: 10.1016/j.revmed.2021.10.249
- Khitri MY, Hadjadj J, Mekinian A, Jachiet V. VEXAS syndrome: an update. Joint Bone Spine 2024;91:105700. doi: 10.1016/j.jbspin.2024.105700
- Kouranloo K, Ashley A, Zhao SS, Dey M. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review. Rheumatol Int 2023;43:1023–1032. doi: 10.1007/s00296-022-05266-2